Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.

Circulation·2026
Same author

Advancing in-hospital mortality prediction for acute myocardial infarction: An analysis from the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry.

American heart journal·2026
Same author

Advancing quality in post-acute cardiovascular and stroke care: Why national leadership and certification matter.

The American journal of medicine·2026
Same author

Post-acute cardiovascular and stroke care and the potential of certification programs: A 'Call to Action'.

The American journal of medicine·2026
Same author

Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization.

Journal of the Society for Cardiovascular Angiography & Interventions·2024

相关实验视频

Updated: May 10, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

通过皮肤进行的冠状动脉干预和冠状动脉旁路移植在急性心肌梗塞后因心脏性休克而复杂后进行的比较:来自应急重新血管化心脏性休克 (SHOCK) 的封闭冠状动脉试验的结果.

Harvey D White1, Susan F Assmann, Timothy A Sanborn

  • 1Green Lane Cardiovascular Service, Auckland City Hospital, Auckland 1030, New Zealand. HarveyW@adhb.govt.nz

Circulation
|September 28, 2005
PubMed
概括

针对心脏性休克的紧急再血管化显示,穿皮冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG) 的存活率相似. 对于患有广泛冠状动脉疾病的患者来说,PCI和CABG都是可行的选择.

更多相关视频

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

相关实验视频

Last Updated: May 10, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

科学领域:

  • 心脏病学 心脏病学
  • 干预心脏病学 干预心脏病学
  • 心脏外科手术 心脏外科手术

背景情况:

  • 我们是否应紧急进行心脏性休克 (SHOCK) 的封闭冠状动脉再血管化试验确定了急性心肌梗塞患者心脏性休克的紧急再血管化的生存益处.
  • 在这种高风险人群中,冠状动脉旁路移植 (CABG) 与穿皮冠状动脉干预 (PCI) 的比较有效性仍未确定.

研究的目的:

  • 为了在SHOCK试验中比较PCI与CABG的30天和1年的生存结果,在SHOCK试验中经历心肌梗塞后心脏性休克的患者中.

主要方法:

  • 分析了来自SHOCK试验的128名患者,这些患者因心脏性休克而经历了紧急再血管化.
  • 患者接受PCI (n=81) 或CABG (n=47) 治疗,根据患者个体特征进行程序选择.
  • 在PCI和CABG组之间对基线人口统计,血液动力学状况,疾病严重程度,再血管化的完整性和生存率进行比较.

主要成果:

  • 与PCI组相比,接受CABG的患者患糖尿病,三血管疾病和左主冠状动脉疾病的患病率更高.
  • 尽管CABG组的冠心病更复杂,但30天生存率相似 (CABG组的57.4%,PCI组的55.6%,P=0.86).
  • 一年生存率也显示,两组之间没有显著差异 (46.8%的CABG与51.9%的PCI,P=0.71).

结论:

  • 在心脏性休克的紧急重血管化背景下,PCI和CABG显示了可比的30天和1年的生存结果.
  • 冠状动脉旁路移植是广泛冠状动脉疾病和心脏性休克患者的有价值的治疗选择,补充PCI策略.